1. Huang, Yi, Yu, Zhou, Zheng, Min, Huang, Honglan, Zhao, Lijin. 2022. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC. In Molecular medicine reports, 25, . doi:10.3892/mmr.2022.12640. https://pubmed.ncbi.nlm.nih.gov/35169860/
2. Krause, Amanda, Mitchell, Claire, Essop, Fahmida, Rudnicki, Dobrila, Margolis, Russell. 2015. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 168, 573-85. doi:10.1002/ajmg.b.32332. https://pubmed.ncbi.nlm.nih.gov/26079385/
3. Hu, Xiaotong, Kuang, Yeye, Li, Lili, Tao, Qian, He, Chao. 2017. Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers. In Theranostics, 7, 2150-2163. doi:10.7150/thno.18185. https://pubmed.ncbi.nlm.nih.gov/28656064/
4. Stevanin, Giovanni, Fujigasaki, Hiroto, Lebre, Anne-Sophie, Brice, Alexis, Durr, Alexandra. 2003. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. In Brain : a journal of neurology, 126, 1599-603. doi:. https://pubmed.ncbi.nlm.nih.gov/12805114/
5. Lehnart, Stephan E, Wehrens, Xander H T. 2022. The role of junctophilin proteins in cellular function. In Physiological reviews, 102, 1211-1261. doi:10.1152/physrev.00024.2021. https://pubmed.ncbi.nlm.nih.gov/35001666/
智鼠故事 
